Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Flex Pharma, Inc.

NASDAQ: FLKSHealthcare / Biotechnology / USA
0.360000.00Vol 1 618 9641Y Perf -91.52%
Feb 15th, 2019 16:00
BID0.3500 ASK0.3600
Open0.3600 Previous Close0.3600
Pre-Market0.35 After-Trading0.34
 -0.01 -2.78%  -0.02 -5.56%
Target Price
1.00 
Analyst Rating
Hold 3.00
Potencial %
177.78 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.15 
Earnings Date
6th Mar 2019

Today's Price Range

0.33000.3700

 

52wk Range

0.26008.98

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
9.09%
3 Months
-20.00%
6 Months
-32.08%
1 Year
-91.52%
3 Years
-94.88%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
FLKS0.36000.00000.00
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.50
Current Ratio
4.70
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
48.90
EBIT Margin
-2 938.30
EBITDA Margin
-2 912.10
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.52
PS Ratios
8.56
Price to Cash Flow
-
Price to Free Cash Flow
-0.30
Cash Flow Per Share
-1.46
Price to Tangible Book
0.52
Book Value per Share
0.61
Enterprise Value (in ths.)
-7 269
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-118.32
Return on Assets (5Y Avg)
-
ROA last 12 Months
-101.34
Return on Capital (5Y Avg)
-
ROC last 12 Months
-118.32
Return on invested Capital Q
-21.57
Return on invested Capital Y
-77.88
Assets Turnover
0.00
Receivables Turnover
11.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
665
Revenue per Share
0.04
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.15-
Q02 2018-0.39-0.50-28.21
Q01 2018-0.50-0.468.00
Q04 2017-0.56-0.4617.86
Q03 2017-0.62-0.5412.90
Q02 2017-0.63-0.5119.05
Q01 2017-0.63-0.4922.22
Q04 2016-0.84-0.4842.86
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2526.47Positive
12/2018 QR-0.1361.76Positive
12/2018 FY-1.230.00-
12/2019 FY-0.550.00-
Next Report Date6th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 618 964
Shares Outstanding (in ths.)18 069
Trades Count967
Dollar Volume530 929
Avg. Volume1 855 823
Avg. Weekly Volume785 451
Avg. Monthly Volume570 713
Avg. Quarterly Volume1 240 537

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

65%35%

Bearish Bullish

38%62%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News